Blueprint Medicines Corp (NASDAQ:BPMC)

Delayed Data
As of Dec 03
 -4.28 / -4.34%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 14 analysts offering 12-month price forecasts for Blueprint Medicines Corp have a median target of 121.50, with a high estimate of 152.00 and a low estimate of 84.00. The median estimate represents a +28.94% increase from the last price of 94.23.

Analyst Recommendations

The current consensus among 15 polled investment analysts is to Buy stock in Blueprint Medicines Corp. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 59.00%
Growthannually -213.86%


Growthquarterly 308.26%
Growthannually -78.34%
Key to the earnings and sales forecast charts.